Intravitreal conbercept for diabetic macular oedema: 2-year results from a randomised controlled trial and open-label extension study.

Liu K, Wang H, He W, Ye J, Song Y, Wang Y, Liu X, Wu Z, Chen S, Fan K, Liu Y, Zhang F, Li Z, Liu L, Zhang J, Zhang X, Ye J, Liang X, Li X, Ke X, Wu Q, Li J, Tao S, Wang X, Rosenfeld P, Heier JS, Kaiser P, Xu X

Open source

DOI: 10.1136/bjophthalmol-2020-318690
Published: 2022 Oct
Container: The British journal of ophthalmology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1136/bjophthalmol-2020-318690,
  title = {Intravitreal conbercept for diabetic macular oedema: 2-year results from a randomised controlled trial and open-label extension study.},
  author = {Liu K and Wang H and He W and Ye J and Song Y and Wang Y and Liu X and Wu Z and Chen S and Fan K and Liu Y and Zhang F and Li Z and Liu L and Zhang J and Zhang X and Ye J and Liang X and Li X and Ke X and Wu Q and Li J and Tao S and Wang X and Rosenfeld P and Heier JS and Kaiser P and Xu X},
  year = {2022},
  journal = {The British journal of ophthalmology},
  doi = {10.1136/bjophthalmol-2020-318690},
  url = {https://doi.org/10.1136/bjophthalmol-2020-318690}
}

RIS

TY  - JOUR
TI  - Intravitreal conbercept for diabetic macular oedema: 2-year results from a randomised controlled trial and open-label extension study.
AU  - Liu K
AU  - Wang H
AU  - He W
AU  - Ye J
AU  - Song Y
AU  - Wang Y
AU  - Liu X
AU  - Wu Z
AU  - Chen S
AU  - Fan K
AU  - Liu Y
AU  - Zhang F
AU  - Li Z
AU  - Liu L
AU  - Zhang J
AU  - Zhang X
AU  - Ye J
AU  - Liang X
AU  - Li X
AU  - Ke X
AU  - Wu Q
AU  - Li J
AU  - Tao S
AU  - Wang X
AU  - Rosenfeld P
AU  - Heier JS
AU  - Kaiser P
AU  - Xu X
PY  - 2022
JO  - The British journal of ophthalmology
DO  - 10.1136/bjophthalmol-2020-318690
UR  - https://doi.org/10.1136/bjophthalmol-2020-318690
ER  -

APA

K, L., H, W., W, H., J, Y., Y, S., Y, W., X, L., Z, W., S, C., K, F., Y, L., F, Z., Z, L., L, L., J, Z., X, Z., J, Y., X, L., X, L., X, K., Q, W., J, L., S, T., X, W., P, R., JS, H., P, K., & X, X. (2022). Intravitreal conbercept for diabetic macular oedema: 2-year results from a randomised controlled trial and open-label extension study.. The British journal of ophthalmology. https://doi.org/10.1136/bjophthalmol-2020-318690

Source records

pubmed · retrieved 2026-09-27T12:27:39.992Z